Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06849063Recruiting

Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE

Role: lead

NCT06526442Recruiting

MRE for Diagnosis of Pancreatic Masses

Role: lead

NCT06510036Recruiting

Assessment of Pancreatic Physiological and Pathological Characteristics Based on Spectral CT

Role: lead

All 3 trials loaded